The National Pharmaceutical Pricing Authority (NPPA) has sought manufacturers and marketing companies of iohexol injection 300 mg iodine per ML, a diagnostic agent, to submit price and market data on ...
Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as Octavian Therapeutics to align with its “growth ambitions and its ...
Algeness® is the first officially approved agarose-based injection filler in China. Algeness® is the culmination of many years of scientific and clinical research to define a novel ...
Dr. Horst Lindhofer, Chief Executive Officer of Lindis Biotech, added: "We are delighted to receive marketing approval for catumaxomab. The approval highlights its potential to address the ...
Dr. Horst Lindhofer, Chief Executive Officer of Lindis Biotech, added: "We are delighted to receive marketing approval for catumaxomab. The approval highlights its potential to address the significant ...
The probe found widespread noncompliance and violations of federal law in how health plans and insurers cover mental health care, echoing the findings of a recent ProPublica investigation. Get to know ...
Algeness® is the first officially approved agarose-based injection filler in China. According to Doug Abel, President and CEO of AAT, "We are excited and look forward to the entry of Algeness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback